1. Home
  2. CNQ vs BSX Comparison

CNQ vs BSX Comparison

Compare CNQ & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Canadian Natural Resources Limited

CNQ

Canadian Natural Resources Limited

HOLD

Current Price

$39.66

Market Cap

98.0B

Sector

N/A

ML Signal

HOLD

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$44.19

Market Cap

93.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNQ
BSX
Founded
1973
1979
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.0B
93.4B
IPO Year
2001
2010

Fundamental Metrics

Financial Performance
Metric
CNQ
BSX
Price
$39.66
$44.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
22
Target Price
$57.00
$93.18
AVG Volume (30 Days)
8.8M
21.1M
Earning Date
05-07-2026
04-22-2026
Dividend Yield
3.68%
N/A
EPS Growth
N/A
55.20
EPS
N/A
0.90
Revenue
N/A
$9,076,000,000.00
Revenue This Year
$5.85
$11.85
Revenue Next Year
N/A
$10.16
P/E Ratio
$18.33
$49.13
Revenue Growth
N/A
12.49
52 Week Low
$29.30
$43.89
52 Week High
$51.34
$109.50

Technical Indicators

Market Signals
Indicator
CNQ
BSX
Relative Strength Index (RSI) 28.66 28.43
Support Level $30.68 N/A
Resistance Level $43.15 $50.14
Average True Range (ATR) 1.08 1.37
MACD -0.56 0.08
Stochastic Oscillator 7.89 4.61

Price Performance

Historical Comparison
CNQ
BSX

About CNQ Canadian Natural Resources Limited

Canadian Natural Resources is the largest producer of oil and the second-largest producer of natural gas in Canada. It is principally involved in extracting heavy oils, natural gas, and bitumen through its drilling and mining operations. Bitumen from mining operations is upgraded into synthetic crude oil. Commodities produced are primarily exported to the US via pipeline. The company also has smaller offshore production operations in the North Sea and Africa.

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: